MGNX - MacroGenics GAAP EPS of -$0.15 misses by $0.58 revenue of $58.8M misses by $22.08M
2024-03-07 16:12:26 ET
More on MacroGenics
- MacroGenics: Evaluating Its Buy Status After A 200% Surge On Prostate Cancer Prospects
- MacroGenics: Trying To Build A Better Everything
- MacroGenics Q4 2023 Earnings Preview
- MacroGenics stock climbs 13% in wake of upgrade by Citi
- Seeking Alpha’s Quant Rating on MacroGenics